Republicans have swept the 2024 elections, returning Donald Trump to the White House as the 47th President and flipping the Senate to a Republican majority. Having narrowly maintained control of the House of Representatives,...more
12/11/2024
/ Acquisitions ,
Affordable Care Act ,
Affordable Housing ,
Antitrust Provisions ,
Canada ,
Capital Formation ,
Centers for Disease Control and Prevention (CDC) ,
China ,
Clean Air Act ,
Colleges ,
Congressional Investigations & Hearings ,
Coronavirus/COVID-19 ,
Data Privacy ,
Department of Energy (DOE) ,
Department of Justice (DOJ) ,
Deregulation ,
Digital Assets ,
Drinking Water ,
Drug Pricing ,
Electric Vehicles ,
Energy Sector ,
Enforcement ,
Environmental Protection Agency (EPA) ,
Exports ,
Federal Trade Commission (FTC) ,
Final Rules ,
Financial Services Industry ,
Food and Drug Administration (FDA) ,
Fraud ,
Greenhouse Gas Emissions ,
Healthcare ,
Imports ,
Infrastructure ,
Lead ,
Medicaid ,
Medicare Advantage ,
Mergers ,
Mexico ,
Money Laundering ,
NAFTA ,
National Institute of Health (NIH) ,
Nuclear Power ,
Offshore Drilling ,
Offshore Wind ,
Oil & Gas ,
PFAS ,
Popular ,
Social Media ,
Tariffs ,
Tax Cuts ,
Technology ,
Transparency ,
Trump Administration ,
United States-Mexico-Canada Agreement (USMCA) ,
Universities ,
Waivers
Six months into the 117th Congress, the U.S. Senate has recently increased its oversight activities following a slow start. Since April, newly empowered Democratic Members have launched or requested more than 20 inquiries...more
7/6/2021
/ Anti-Competitive ,
Biden Administration ,
Congressional Oversight ,
Coronavirus/COVID-19 ,
Cryptocurrency ,
Cybersecurity ,
Diversity and Inclusion Standards (D&I) ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
Manufacturers ,
Pharmaceutical Industry ,
Popular ,
Relief Measures
On July 24, 2020, President Trump issued a series of Executive Orders to address prescription drug costs, one of which specifically focuses on facilitating drug importation, a longstanding goal of the Trump Administration....more
7/31/2020
/ Department of Health and Human Services (HHS) ,
Executive Orders ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
Food and Drug Administration (FDA) ,
Medicare Prescription Drug Improvement and Modernization Act (MMA) ,
Notice of Proposed Rulemaking (NOPR) ,
Prescription Drugs ,
Public Safety ,
State Implementation Plans (SIPs) ,
Trump Administration ,
Waivers
Trump Administration and Testing Companies Receiving Scrutiny -
Throughout the COVID-19 pandemic, both viral and antibody testing have raised significant challenges for the government and private sector. As both federal...more